Quantcast
Last updated on April 17, 2014 at 1:21 EDT

Latest Nucleic acids Stories

2014-02-18 16:26:23

BOULDER, Colo. and SAN FRANCISCO, Feb. 18, 2014 /PRNewswire/ -- With its participation in the 58(th) annual Biophysical Society Meeting from February 15 - 19, along with the 21st International Molecular Medicine Tri-Conference, BiOptix entered a second week highlighting the 404pi SPR platform and new publication data to a global research audience in California. "California continues to be a global center of scientific research," noted Ken Wilczek, Vice President, Sales &...

2014-02-12 08:28:36

New Patent Extends Coverage to Peptide- and Protein-Based Control Agents BASKING RIDGE, N.J., Feb. 12, 2014 /PRNewswire/ -- Regado Biosciences, Inc. (Nasdaq: RGDO), a biopharmaceutical company focused on the late-stage clinical development of its first-in-class, actively controllable antithrombotic drug system, REG1, today announced that the United States Patent and Trademark Office (USPTO) has issued an important patent that expands protection of Regado's core technology platform...

2014-01-28 09:10:37

Drugs comprised of single strands of DNA, called aptamers, can bind to targets inside tumor cells causing cell death. But these DNA drugs cannot readily get inside tumor cells on their own. Effective delivery of DNA aptamers using a natural polysaccharide as a carrier is described in an article in Nucleic Acid Therapeutics, a peer-reviewed journal from Mary Ann Liebert, Inc. publishers. The article is available on the Nucleic Acid Therapeutics website. Tatyana Zamay and coauthors,...

2013-12-06 00:00:07

Korean researchers propose simple model to explain DNA helicity and elasticity on a nanometer scale A simple mechanical model to effectively implement the well-known double-stranded structure and the elasticity of DNA on a nano-meter scale has been developed by Jae-Hyung Jeon and Wokyung Sung of Pohang University of Science and Technology in the Republic of Korea, in an effort to more comprehensively explore the nucleic acid containing genetic material of cells. The model was published in...

2013-11-08 12:23:40

DUBLIN, November 8, 2013 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/tfh2m9/aptamers_market) has announced the addition of the "Global Aptamers Market Technology Trend Analysis Market Report 2013-2018" [http://www.researchandmarkets.com/research/tfh2m9/aptamers_market ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) The global aptamers market is valued at $287 million in 2013 and is...

2013-10-30 23:26:16

Xtalks presents an exciting live webinar on Thursday, November 7, 2013 at 2:00pm EST (11:00am PST) on RNA Aptamers. Toronto, Canada (PRWEB) October 30, 2013 RNA aptamers are an emerging class of molecules demonstrating significant potential in the diagnosis and treatment of human diseases. RNA aptamers are small, single-stranded RNA molecules that are functionally analogous to antibodies. However, RNA aptamers can be produced by chemical synthesis and their small size, low immunogenicity,...

2013-10-29 23:27:33

Aptamers Market report categorizes the global market into geography, applications, and aptamer type. http://www.marketsandmarkets.com/Market-Reports/aptamers-technology-market-1167.html (PRWEB) October 29, 2013 The "Aptamers Market - Technology Trend Analysis By Applications - Therapeutics, Diagnostics, Biosensors, Drug Discovery, Biomarker Discovery, Research Applications with Market Landscape Analysis - Global Forecasts to 2018 " analyzes and studies the major market drivers,...

2013-09-19 23:37:25

The Oligo Factory, a provider of quality custom DNA/RNA synthesis services, announced plans to expand its facilities to accommodate growing market demand for mg to gram scale custom oligonucleotides, derivatives and modifications. Holliston, MA (PRWEB) September 19, 2013 The Oligo Factory, a provider of quality custom DNA/RNA synthesis services, announced plans to expand its facilities to accommodate growing market demand for mg to gram scale custom oligonucleotides, derivatives and...

2013-08-23 04:20:21

HOERSHOLM, Denmark and SAN DIEGO, Aug. 23, 2013 /PRNewswire/ -- Santaris Pharma A/S, a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, today announced that its long term partner, Shire has extended the existing partnership in the rare genetic disease space. (Logo: http://photos.prnewswire.com/prnh/20100111/SPLOGO) Under the terms of the extended agreement, Shire will have the right to nominate additional...

2013-08-10 23:01:10

Transparency Market Research adds new "Aptamers Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" market research report to its report store. Browse report: http://www.transparencymarketresearch.com/aptamers-market.html Albany, New York (PRWEB) August 10, 2013 Aptamers refer to short strands of nucleic acids or peptide molecules capable of forming secondary and tertiary structures. These molecules bind specifically to the cellular targets...